{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:52:55Z","timestamp":1753890775225,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pheochromocytomas (PCCs) and paragangliomas (PGLs) (PPGLs) are rare tumours arising from the chromaffin cells. There is evidence suggesting a link between hypoxemia and PPGLs. Chronic hypoxia can lead to gain of function somatic variants in the <jats:italic>EPAS1<\/jats:italic> gene that encodes for hypoxia-inducible factor 2-alpha (HIF-2\u03b1), involved in PPGL tumorigenesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To describe a rare case of PCC in a pulmonary transplant patient and characterize the tumour\u2019s genetic background.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Case<\/jats:title><jats:p>A 47 year-old man underwent a lung transplant for chronic obstructive pulmonary disease associated with alpha-1 antitrypsin deficiency. He required home oxygen therapy for 3 years prior to transplant. Nineteen years after transplant, a CT-scan revealed a 5.8\u00a0cm x 3.9\u00a0cm heterogeneous right adrenal mass (HU of 7). Initial assessments indicated elevated 24-hour urinary catecholamines. Consequently, the patient underwent laparoscopic right adrenalectomy, confirming the PCC diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Genetic studies<\/jats:title><jats:p>1) Germline PPGL multigene panel: After consent, the patient underwent a panel of 14 susceptibility genes for PPGLs that revealed no pathogenic variants. 2) Somatic genetic analysis for <jats:italic>EPAS1<\/jats:italic> gene found no variants. However, tumoral RNA sequencing unveiled activation of the HIF pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We describe a rare case of PCC in a pulmonary transplant recipient, with genetic analyses showing no germline pathogenic variants and no somatic variants in the <jats:italic>EPAS1<\/jats:italic> gene. RNA sequencing highlighted HIF pathway activation and angiogenic implications. Further research is necessary to elucidate the genetic and molecular mechanisms underlying PCCs in this specific case and determine its link with hypoxemia in the context of pulmonary disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1481906","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:22:17Z","timestamp":1738819337000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic characterization of a rare case of pheochromocytoma in a pulmonary transplant patient"],"prefix":"10.3389","volume":"15","author":[{"given":"St\u00e9fanie","family":"Parisien-La Salle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Corbeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Morisset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Beauregard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"R\u00e4kel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie","family":"Labrecque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"T\u00e9treault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Cohade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2021","journal-title":"Endocr Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0215","article-title":"15 YEARS OF PARAGANGLIOMA: metabolism and pheochromocytoma\/paraganglioma","volume":"22","author":"Mannelli","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(73)80012-7","article-title":"High altitude hypoxia and chemodectomas","volume":"4","author":"Saldana","year":"1973","journal-title":"Hum Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3863","article-title":"Pheochromocytoma and paraganglioma in cyanotic congenital heart disease","volume":"100","author":"Opotowsky","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00515","article-title":"Update of pheochromocytoma syndromes: genetics, biochemical evaluation, and imaging","volume":"9","author":"Alrezk","year":"2018","journal-title":"Front Endocrinology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1385\/EP:17:2:201","article-title":"Genetic analysis of high altitude paragangliomas","volume":"17","author":"Jech","year":"2006","journal-title":"Endocr Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"L21","DOI":"10.1530\/EJE-21-0258","article-title":"Incidence of pheochromocytoma and paraganglioma varies according to altitude: meta-regression analysis","volume":"184","author":"Leung","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0680","article-title":"Incidence of PPGL according to altitude \u2013 Calendar time is of the essence","volume":"186","author":"Ebbehoj","year":"2022","journal-title":"Eur J Endocrinology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1716652","article-title":"EPAS1 mutations and paragangliomas in cyanotic congenital heart disease","volume":"378","author":"Vaidya","year":"2018","journal-title":"New Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00087","article-title":"Genetic characterization of gnRH\/LH-responsive primary aldosteronism","volume":"103","author":"Gagnon","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/chd.12625","article-title":"Pheochromocytoma and paraganglioma in Fontan patients: Common more than expected","volume":"13","author":"Song","year":"2018","journal-title":"Congenit Heart Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1297\/cpe.25.59","article-title":"Pheochromocytoma complicated by cyanotic congenital heart disease: a case report","volume":"25","author":"Yamamoto","year":"2016","journal-title":"Clin Pediatr Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.598656","article-title":"Seven novel genes related to cell proliferation and migration of VHL-mutated pheochromocytoma","volume":"12","author":"Gao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030560","article-title":"Treatment of pheochromocytoma cells with recurrent cycles of hypoxia: A new pseudohypoxic","volume":"11","author":"Helm","year":"2022","journal-title":"In Vitro Model Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.21037\/atm.2020.02.126","article-title":"Malignancy after lung transplantation","volume":"8","author":"Shtraichman","year":"2020","journal-title":"Ann Transl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-214719","article-title":"Unusual presentation of phaeochromocytoma","volume":"2016","author":"Hope","year":"2016","journal-title":"BMJ Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0026","article-title":"Treatment-resistant hypertension in a post-transplant patient with cystic fibrosis: a rare case of phaeochromocytoma","volume":"2021","author":"Tansey","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the patient with adrenal incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock","year":"2020","journal-title":"Endocrine Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0006","article-title":"Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study","volume":"178","author":"Buitenwerf","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.3390\/ijms24065153","article-title":"Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma","volume":"24","author":"Lopez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(06)72809-9","article-title":"Immunosuppressive drug-induced diabetes","volume":"32","author":"Penfornis","year":"2006","journal-title":"Diabetes Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.12.044","article-title":"Hypertension in CKD: core curriculum 2019","volume":"74","author":"Ku","year":"2019","journal-title":"Am J Kidney Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1481906\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:22:19Z","timestamp":1738819339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1481906\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":25,"alternative-id":["10.3389\/fendo.2024.1481906"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1481906","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"article-number":"1481906"}}